OTC · Financial Statements

CYduct Diagnostics, Inc. (CYDX) Financial Statements

$2.70 OTC: CYDX Market Cap $14.15M

CYduct Diagnostics, Inc. most recently reported annual revenue of $0, net profit of $0. See the full income statement, balance sheet, and cash flow statement below, plus valuation and return ratios.

Annual Financials (USD)

Metric20202021202220232024
Revenue$0$0$0$0$0
Operating Profit$0$0$0$0$0
Net Profit$0$0$0$0$0
EPS$-0.07$-0.08$-0.09$-0.08$-0.08
Op Margin-230.6%-429.1%-372.6%-448.5%-513.8%

Balance Sheet (USD)

Metric20202021202220232024
Total Assets$0$0$0$0$0
Total Liabilities$1.0M$2.0M$2.0M$2.0M$3.0M
Cash$0$0$0$0$0
Borrowings$0$1.0M$1.0M$1.0M$1.0M

Cash Flow (USD)

Metric20202021202220232024
Operating Cash Flow$0$0$0$0$0
Investing Cash Flow$0$0$0$0$0
Financing Cash Flow$0$0$0$0$0
Net Cash Flow$0$0$0$0$0
Free Cash Flow$0$0$0$0$0

Valuation & Return Ratios

MetricValue
PEG Ratio-2.82
EV / EBITDA-49.89
FCF Yield0.07%
Quick Ratio0.01
Interest Coverage-5.81
Return 1Y971.00%
Return 3Y499.87%
Return 5Y—

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)Eli Lilly (LLY)JPMorgan (JPM)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksAll stock screens
CYDX Overview CYDX Dividend Run Stock Screener